Alert Added Successfully

Endocrinology


               
Article Title Year Authour(s) Journal Subject Expert Rating Evidence Ranking
1. Promise of Immune Modulation to Inhibit Atherogenesis 2007 Binder, C...J..., Hartvigsen, K..., Witztum, J...L... J Am Coll Cardiol Endocrinology D
2. Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology 2006 Budoff, M.J., Achenbach, S., Blumenthal, R.S. Circulation Endocrinology C
3. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study 2006 Deedwania, P. Lancet Endocrinology A
4. Effect of Different Antilipidemic Agents and Diets on Mortality: A Systematic Review 2005 Studer, M., Briel, M., Leimenstoll, B. Arch Intern Med Endocrinology B
5. Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids 2008 Ge, H..., Li, X..., Weiszmann, J... Endocrinology Endocrinology D
6. Waist Circumference and Cardiometabolic Risk: A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association 2007 Klein, S..., Allison, D...B..., Heymsfield, S...B... Diabetes Care Endocrinology C
7. Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40mg Daily (from the ASTEROID Study) 2009 Wiviott, S...D..., Mohanavelu, S..., Raichlen, J...S... Am J Cardiol Endocrinology A
8. Alcohol and the Cardiovascular System: Research Challenges and Opportunities 2005 Lucas, D.L., Brown, R.A., Wassef, M. J Am Coll Cardiol Endocrinology C
9. Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial 2007 Tardif, J...-.C..., for the Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators. JAMA Endocrinology A
10. Statin and β-Blocker Therapy and the Initial Presentation of Coronary Heart Disease 2006 Go, A.S. Ann Intern Med Endocrinology B
11. Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial 2007 Tardif, J...-.C..., for the Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators. JAMA Endocrinology A
12. Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators: The Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) Randomized Trial 2006 Brouwer, I.A. JAMA Endocrinology A
13. Trends in Serum Lipids and Lipoproteins of Adults, 1960–2002 2005 Carroll, M.D., Lacher, D.A., Sorlie, P.D. JAMA Endocrinology B
14. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial 2006 Nissen, S.E. JAMA Endocrinology B
15. Association between n–3 fatty acid consumption and ventricular ectopy after myocardial infarction 2009 Smith, P...J..., Blumenthal, J...A..., Babyak, M...A... Am J Clin Nutr Endocrinology B
16. Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease 2005 LaRosa, J.C., for the Treating to New Targets (TNT) Investigators. N Engl J Med Endocrinology A
17. Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3 2008 Chang, W..., Goodarzi, M...O..., Williams, H... Fertil Steril Endocrinology B
18. Consequences of Change in Waist Circumference on Cardiometabolic Risk Factors Over 9 Years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) 2007 Balkau, B..., for the DESIR Study Group. Diabetes Care Endocrinology B
19. Obesity and the Risk of Myocardial Infarction in 27 000 participants from 52 countries: A Case-Control Study 2005 Yusuf, S., on behalf of the INTERHEART Study Investigators. Lancet Endocrinology B
20. Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival 2007 Leeper, N...J..., Reza, A..., deGoma, E...M... Circulation Endocrinology B
21. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention 2006 Zhou, Z., Rahme, E., Pilote, L. Am Heart J Endocrinology A
22. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis 2006 Hackam, D.G., Mamdani, M., Li, P. Lancet Endocrinology B
23. Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis 2007 Nicholls, S...J..., Tuzcu, E...M..., Sipahi, I... JAMA Endocrinology B
24. Non—HDL Cholesterol, Apolipoproteins A-1 and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women 2005 Ridker, P.M., Rifai, N., Cook, N.R. JAMA Endocrinology B
25. Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease 2009 Faergeman, O..., Holme, I..., Fayyad, R... Am J Cardiol Endocrinology A
26. Dietary Fiber and Risk of Coronary Heart Disease: A Pooled Analysis of Cohort Studies 2004 Pereira, M.A., O'Reilly, E., Augustsson, K. Arch Intern Med Endocrinology B
27. Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study) 2009 Cui, Y..., Watson, D...J..., Girman, C...J... Am J Cardiol Endocrinology B
28. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins 2005 Cholesterol Treatment Trialists' (CTT) Collaborators. Lancet Endocrinology A
29. Dietary fat and sleep duration in Chinese men and women 2008 Shi, Z..., McEvoy, M..., Luu, J... Int J Obes (Lond) Endocrinology B
30. Safety of Aggressive Lipid Management 2007 Davidson, M...H..., Robinson, J...G... J Am Coll Cardiol Endocrinology B
31. Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease: Impact of a High-Density Lipoprotein–Bound Antioxidant in Secondary Prevention 2009 Regieli, J...J..., Jukema, J...W..., Doevendans, P...A... J Am Coll Cardiol Endocrinology A
32. Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial 2009 Pellegrini, C...N..., Vittinghoff, E..., Lin, F... Heart Endocrinology B
33. Diets and Cardiovascular Disease: An Evidence-Based Assessment 2005 Parikh, P., McDaniel, M.C., Ashen, M.D. J Am Coll Cardiol Endocrinology E
34. Arterial Structure and Function After Recovery From the Metabolic Syndrome: The Cardiovascular Risk in Young Finns Study 2010 Koskinen, J..., Magnussen, C...G..., Taittonen, L... Circulation Endocrinology A
35. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study 2006 Shepherd, J..., for the Treating to New Targets Investigators. Diabetes Care Endocrinology B
36. Potential Impact on Cardiovascular Public Health of Over-the-Counter Statin Availability 2006 Brass, E.P., Allen, S.E., Melin, J.M. Am J Cardiol Endocrinology C
37. Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis 2007 Nicholls, S...J..., Tuzcu, E...M..., Sipahi, I... JAMA Endocrinology B
38. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA) 2009 Ding, J..., Hsu, F...-.C..., Harris, T...B... Am J Clin Nutr Endocrinology B
39. High-Density Lipoprotein as a Therapeutic Target: A Systematic Review 2007 Singh, I...M..., Shishehbor, M...H..., Ansell, B...J... JAMA Endocrinology B
40. Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure: A Preliminary Report 2005 Fukuta, H., Sane, D.C., Brucks, S. Circulation Endocrinology B
41. C-Reactive Protein Levels and Outcomes After Statin Therapy 2005 Ridker, P.M., for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. N Engl J Med Endocrinology B
42. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects 2009 Qin, Y..., Xia, M..., Ma, J... Am J Clin Nutr Endocrinology B
43. Optimal Medical Therapy with or without PCI for Stable Coronary Disease 2007 Boden, W...E..., for the COURAGE Trial Research Group. N Engl J Med Endocrinology A
44. Impact of Prior Statin Therapy on Arrhythmic Events in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]) 2009 Vedre, A..., for the GRACE Investigators. Am J Cardiol Endocrinology B
45. The Effect of Early, Intensive Statin Therapy on Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials 2006 Hulten, E., Jackson, J.L., Douglas, K. Arch Intern Med Endocrinology A
46. Optimal Medical Therapy with or without PCI for Stable Coronary Disease 2007 Boden, W...E..., for the COURAGE Trial Research Group. N Engl J Med Endocrinology A
47. Distribution of Lipoproteins by Age and Gender in Adolescents 2006 Jolliffe, C.J., Janssen, I. Circulation Endocrinology E
48. Promise of Immune Modulation to Inhibit Atherogenesis 2007 Binder, C...J..., Hartvigsen, K..., Witztum, J...L... J Am Coll Cardiol Endocrinology D
49. The Issue of Statin Safety: Where Do We Stand? 2005 Grundy, S.M. Circulation Endocrinology C
50. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study 2010 Burgess, D...C..., Hunt, D..., Li, L... Eur Heart J Endocrinology B
51. Reduction in the Incidence of Acute Myocardial Infarction Associated With a Citywide Smoking Ordinance 2006 Bartecchi, C., Alsever, R.N., Nevin-Woods, C. Circulation Endocrinology B
52. Dysfunctional Proinflammatory High-Density Lipoproteins Confer Increased Risk of Atherosclerosis in Women With Systemic Lupus Erythematosus 2009 McMahon, M..., Grossman, J..., Skaggs, B... Arthritis Rheum Endocrinology B
53. Essential Nutrients: Food or Supplements? Where Should the Emphasis Be? 2005 Lichtenstein, A.H., Russell, R.M. JAMA Endocrinology C
54. Cardiovascular Benefit of Magnitude of Low-Density Lipoprotein Cholesterol Reduction: A Comparison of Subgroups by Age 2009 Rahilly-Tierney, C...R..., Lawler, E...V..., Scranton, R...E... Circulation Endocrinology B
55. Adherence to the Mediterranean Diet Is Inversely Associated With Circulating Interleukin-6 Among Middle-Aged Men: A Twin Study 2008 Dai, J..., Miller, A...H..., Bremner, J...D... Circulation Endocrinology B
56. Waist Circumference and Cardiometabolic Risk: A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association 2007 Klein, S..., Allison, D...B..., Heymsfield, S...B... Diabetes Care Endocrinology C
57. Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B 2006 Kastelein, J.J.P., Wedel, M.K., Baker, B.F. Circulation Endocrinology A
58. Cholesterol Levels After 3 Days of High-Dose Simvastatin in Patients at Moderate to High Risk for Coronary Events 2005 Michelena, H.I., Osorio, L.A., Citkowitz, E. Int J Cardiol Endocrinology A
59. High Attributable Risk of Elevated C-Reactive Protein Level to Conventional Coronary Heart Disease Risk Factors: The Third National Health and Nutrition Examination Survey 2005 Miller, M., Zhan, M., Havas, S. Arch Intern Med Endocrinology B
60. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2 2009 Santos, R...D..., on behalf of the L-TAP 2 Investigators. Am Heart J Endocrinology A
61. Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task Force 2006 McKenney, J.M., Davidson, M.H., Jacobson, T.A. Am J Cardiol Endocrinology C
62. Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study 2007 El Harchaoui, K..., van der Steeg, W...A..., Stroes, E...S...G... J Am Coll Cardiol Endocrinology B
63. Adipokines, Inflammation, and Visceral Adiposity across the Menopausal Transition: A Prospective Study 2009 Lee, C...G..., Carr, M...C..., Murdoch, S...J... J Clin Endocrinol Metab Endocrinology B
64. Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs 2004 Graham, D.J., Staffa, J.A., Shatin, D. JAMA Endocrinology B
65. Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus 2010 The ACCORD Study Group. N Engl J Med Endocrinology A
66. Effect of Torcetrapib on the Progression of Coronary Atherosclerosis 2007 Nissen, S...E..., for the ILLUSTRATE Investigators. N Engl J Med Endocrinology A
67. Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in Japan: The Ohsaki Study 2006 Kuriyama, S., Shimazu, T., Ohmori, K. JAMA Endocrinology B
68. Acute Effects of Statin Therapy on Coronary Atherosclerosis Following an Acute Coronary Syndrome 2009 Rodés-Cabau, J..., Tardif, J...-.C..., Cossette, M... Am J Cardiol Endocrinology B
69. High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial 2005 Pedersen, T.R. JAMA Endocrinology A
70. Comparison of 80 versus 10mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial) 2010 LaRosa, J...C..., Deedwania, P...C..., Shepherd, J... Am J Cardiol Endocrinology A
71. Consequences of Change in Waist Circumference on Cardiometabolic Risk Factors Over 9 Years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) 2007 Balkau, B..., for the DESIR Study Group. Diabetes Care Endocrinology B
72. Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans 2005 Landmesser, U., Bahlmann, F., Mueller, M. Circulation Endocrinology A
73. Risk Factors for Declining Ankle-Brachial Index in Men and Women 65 Years or Older 2005 Kennedy, M., Solomon, C., Manolio, T.A. Arch Intern Med Endocrinology B
74. Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease 2007 Chan, P...S..., Nallamothu, B...K..., Gurm, H...S... Circulation Endocrinology A
75. Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds 2006 Grundy, S.M. J Am Coll Cardiol Endocrinology C
76. Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease 2007 Chan, P...S..., Nallamothu, B...K..., Gurm, H...S... Circulation Endocrinology A
77. Comparison of Mortality Rates in Statin Users Versus Nonstatin Users in a United States Veteran Population 2006 Mehta, J.L., Bursac, Z., Hauer-Jensen, M. Am J Cardiol Endocrinology B
78. Reporting Rate of Rhabdomyolysis With Fenofibrate + Statin Versus Gemfibrozil + Any Statin 2005 Jones, P.H., Davidson, M.H. Am J Cardiol Endocrinology C
79. Intake of total trans, trans-18:1, and trans-18:2 fatty acids and risk of sudden cardiac death in women 2009 Chiuve, S...E..., Rimm, E...B..., Manson, J...E... Am Heart J Endocrinology B
80. Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial 2006 Howard, B.V., Van Horn, L., Hsia, J. JAMA Endocrinology A
81. 1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus 2009 Oh, J..., Weng, S..., Felton, S...K... Circulation Endocrinology A
82. Safety of Aggressive Lipid Management 2007 Davidson, M...H..., Robinson, J...G... J Am Coll Cardiol Endocrinology B
83. Effectiveness and Tolerability of Ezetimibe Add-on Therapy to a Bile Acid Resin-Based Regimen for Hypercholesterolemia 2004 Xydakis, A.M., Guyton, J.R., Chiou, P. Am J Cardiol Endocrinology B
84. Accuracy of 64-Slice Computed Tomography to Classify and Quantify Plaque Volumes in the Proximal Coronary System: A Comparative Study Using Intravascular Ultrasound 2006 Leber, A.W., Becker, A., Knez, A. J Am Coll Cardiol Endocrinology B
85. Statin Use and Incident Nuclear Cataract 2006 Klein, B.E.K., Klein, R., Lee, K.E. JAMA Endocrinology B
86. Impact of Obesity on Cardiac Geometry and Function in a Population of Adolescents: The Strong Heart Study 2006 Chinali, M., de Simone, G., Roman, M.J. J Am Coll Cardiol Endocrinology B
87. Diets Containing Barley Significantly Reduce Lipids in Mildly Hypercho-lesterolemic Men and Women 2004 Behall, K.M., Scholfield, D.J., Hallfrisch, J. Am J Clin Nutr Endocrinology B
88. Missed opportunities in the secondary prevention of myocardial infarction: An assessment of the effects of statin underprescribing on mortality 2006 Austin, P.C., Mamdani, M.M., Juurlink, D.N. Am Heart J Endocrinology B
89. Statins and the Risk of Colorectal Cancer 2005 Poynter, J.N., Gruber, S.B., Higgins, P.D.R. N Eng/J Med Endocrinology B
90. Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults 2006 Sahyoun, N.R., Jacques, P.F., Zhang, X.L. Am J Clin Nutr Endocrinology B
91. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement 2005 Grundy, S.M., Cleeman, J.I., Daniels, S.R. Circulation Endocrinology C
92. Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival 2007 Leeper, N...J..., Reza, A..., deGoma, E...M... Circulation Endocrinology B
93. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease; 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute [AHA/ACC Guideline] 2006 Smith, S.C Jr., Allen, J., Blair, S.N. Circulation Endocrinology C
94. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice 2008 Osei-Hyiaman, D..., Liu, J..., Zhou, L... J Clin Invest Endocrinology D
95. High-Density Lipoprotein as a Therapeutic Target: A Systematic Review 2007 Singh, I...M..., Shishehbor, M...H..., Ansell, B...J... JAMA Endocrinology B
96. Noninvasive Coronary Angiography With Multislice Computed Tomography 2005 Hoffmann, M.H.K., Shi, H., Schmitz, B.L. JAMA Endocrinology B
97. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack 2006 Amarenco, P., Bogousslavsky, J., Callahan, A. N Engl J Med Endocrinology A
98. Fish Oil Supplementation and Risk of Ventricular Tachycardia and Ventricular Fibrillation in Patients With Implantable Defibrillators: A Randomized Controlled Trial 2005 Raitt, M.H., Connor, W.E., Morris, C. JAMA Endocrinology A
99. Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction 2006 Ho, P.M., Spertus, J.A., Masoudi, F.A. Arch Intern Med Endocrinology B
100. Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer 2005 Eliassen, A.H., Colditz, G.A., Rosner, B. Arch Intern Med Endocrinology B
101. Secondary Prevention of Coronary Artery Disease with Omega-3 Fatty Acids 2006 Jacobson, T.A. Am J Cardiol Endocrinology C
102. Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study 2007 El Harchaoui, K..., van der Steeg, W...A..., Stroes, E...S...G... J Am Coll Cardiol Endocrinology B
103. Atorvastatin in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis 2005 Wanner, C., for the German Diabetes and Dialysis Study Investigators. N Engl J Med Endocrinology A
104. Alcohol consumption and blood lipids in elderly coronary patients 2008 de Jong, H...J...I..., de Goede, J..., Oude Griep, L...M... Metabolism Endocrinology B
105. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study 2006 Shepherd, J..., for the Treating to New Targets Investigators. Diabetes Care Endocrinology B
106. Effect of Combining Psyllium Fiber With Simvastatin in Lowering Cholesterol 2005 Moreyra, A.E., Wilson, A.C., Koraym, A. Arch Intern Med Endocrinology A
107. Effect of Torcetrapib on the Progression of Coronary Atherosclerosis 2007 Nissen, S...E..., for the ILLUSTRATE Investigators. N Engl J Med Endocrinology A
108. Medical Treatment of Peripheral Arterial Disease 2006 Hankey, G.J., Norman, P.E., Eikelboom, J.W. JAMA Endocrinology A
109. Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial 2005 Lonn, E., for the HOPE and HOPE-TOO Trial Investigators. JAMA Endocrinology A
110. Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): A Retrospective Analysis 2009 McMurray, J...J...V..., for the CORONA Study Group. Circulation Endocrinology B
111. Cardiovascular Morbidity Associated with Nonadherence to Statin Therapy 2005 Blackburn, D.F., Dobson, R.T., Blackburn, J.L. Pharmacotherapy Endocrinology B